Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2008
12/30/2008US7470525 allowing cells of microorganism or treated products thereof having an activity of stereoselective hydrolysis of the amide bond of a 2-alkyl-L-cysteinamide or a salt thereof to act on a 2-alkylcysteinamide consisting of a mixture of D- and L-isomers or a salt thereof
12/30/2008CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
12/30/2008CA2223720C Novel uses for thyroid hormones or thyroid hormone-like compounds
12/25/2008US20080319033 3-{3-[5-(4-acetylphenyl)-4-methylthiazol-2-yl]-ureido}-N-tert-butylpropionamide, exhibiting phosphatidylinositol 3-kinase inhibitory activity and used for treating respiratory system disorders, such as asthma
12/25/2008US20080319032 Tetrahydrobenzothiazole analogues as neuroprotective agents
12/25/2008US20080319031 Novel Tyrosine Derivatives
12/25/2008US20080318959 using 3-amino-5-ethyl-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide
12/25/2008US20080318958 New utilities of tricyclic compounds
12/25/2008US20080318956 Inflammatory cytokine release inhibitor
12/25/2008US20080317671 Non-imidazole heterocyclic compounds
12/24/2008WO2008156601A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases
12/24/2008WO2008156573A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/24/2008WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
12/24/2008WO2008155615A2 An improved process for the preparation of cephalosporin antibiotic
12/24/2008WO2008155351A1 Homocysteine analogues
12/24/2008WO2008106080A3 Synthesis of desacetoxytubulysin h and analogs thereof
12/24/2008WO2008033455A3 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
12/24/2008EP2004617A2 Ceramide kinase modulation
12/24/2008EP2004607A2 New compounds
12/24/2008EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
12/24/2008EP2004185A2 Novel heterocyclic diphenyl ethers
12/24/2008CN101328156A Hydroxamic acids derivates containing 1,3 biheterocycle five-membered rings and use thereof
12/24/2008CN100445294C Platinum complex and luminescent element
12/24/2008CA2691309A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases
12/24/2008CA2690410A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/23/2008US7468393 Diarylsulfones as 5-HT2A antagonists
12/23/2008US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression;
12/23/2008US7468360 Therapeutic amides and related compounds
12/23/2008CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity
12/18/2008WO2008154601A1 Anti-viral inhibitors and methods of use
12/18/2008WO2008154563A1 1, 3 - dihydroxy substituted phenylamide glucokinase activators
12/18/2008WO2008152306A2 Novel peptidase substrates
12/18/2008WO2008152305A2 Novel nitroreductase enzymatic substrates
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008US20080312436 Colorless Water-Soluble Organic Luminophores and Intermediates Thereof
12/18/2008US20080312435 Imine Compound
12/18/2008US20080312297 such as N-methoxy-N'-(2-chloropyrid-5-ylmethyl)nitroguanidine, formed by reacting N-nitro-N'-(2-chloropyrid-5-ylmethyl)-S-methylisothiourea and O-methylhydroxylamine; pesticides; insecticides
12/18/2008US20080312293 2-Arylpropionic Acid Derivatives and Pharmaceutical Compositions Containing Them
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312291 Heterocyclic Gaba-b Modulators
12/18/2008US20080312282 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme
12/18/2008US20080312270 Compounds and methods useful for treating asthma and allergic inflammation
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080312223 Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases
12/18/2008US20080312207 Compounds
12/18/2008US20080312206 Chemical Compounds-149
12/18/2008US20080311113 Method for treating adamts-5-associated disease
12/18/2008US20080308770 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors
12/18/2008CA2691987A1 Antibacterial agents
12/17/2008EP2003116A2 Process for the production of organic oxides
12/17/2008EP2001844A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/17/2008EP1753736B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/17/2008CN101326172A Improved jasmonate derivatives, pharmaceutical compositions and methods of use thereof
12/17/2008CN101326171A Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders
12/17/2008CN100443480C Tricyclic compound and its preparation and use
12/17/2008CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands
12/17/2008CN100443477C Substituted benzoxazoles and analogues as estrogenic agents
12/17/2008CN100443475C Compound of 2-substituted alkylacrylate and application thereof
12/16/2008US7465804 3-[p-(substituted benzyloxy)- or p-(substituted -5-thiazolylmethoxy)phenyl]propionic acid derivatives in which the propionic acid is 3-substituted with a carbamoyl-, imidazolyl-, triazolyl-, tetrazolyl-, or oxazolyl group; activating G-protein coupled receptor 40; treatment of type II diabetes
12/16/2008US7465752 Peroxisome Proliferator Activated Receptors modulators; ethyl (R,S)-2-(4-trifluoromethylphenyl)oxypent-4-enoate; dyslipidemia, atherosclerosis and diabetes
12/11/2008WO2008150015A1 Heterobicyclic compounds as kinase inhibitors
12/11/2008WO2008148468A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/11/2008WO2007092364A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment
12/11/2008WO2007061661A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306136 Substituted Ureas and Carbamates
12/11/2008US20080306125 nuclear receptor modulators such as 6-{4-[3-(2,6-Dichloro-phenyl)-5-isopropyl-isoxazol-4-ylmethoxy]-phenyl}-1-isopropyl-1H-indole-3-carboxylic acid, used for treating dyslipidemia, atherosclerosis, diabetes, raising plasma high density lipoproteins, lowering low density lipoproteins and triglycerides
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306067 Modulators of Chemokine Receptor Activity
12/11/2008US20080306060 Fused Thiazole Derivatives as Kinase Inhibitors
12/11/2008US20080306041 Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
12/11/2008US20080305051 Menthane Carboxamide Derivatives Having Cooling Properties
12/11/2008DE112007000299T5 Verfahren zur Herstellung von aromatischer Verbindung Process for the preparation of aromatic compound
12/11/2008CA2689985A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/11/2008CA2689514A1 Heterobicyclic compounds as kinase inhibitors
12/10/2008EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
12/10/2008EP1999120A1 Benzothiazoles having histamine h3 receptor activity
12/10/2008EP1999119A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
12/10/2008CN101321742A Compositions and methods of treating retinal disease
12/10/2008CN101318942A Novel method for preparing vulcanized rubber accelerant DZ with cooling-down circulating water system
12/10/2008CN100441574C Tricyclic compounds, their production and use
12/09/2008US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/09/2008CA2379061C Antibacterial agents
12/04/2008WO2008145616A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/04/2008WO2008145615A2 Aminoazoline and urea derivatives for combating animal pests
12/04/2008WO2008144956A1 New ambroxol compounds, their preparation processes and uses
12/04/2008US20080300285 Chemical Compounds
12/04/2008US20080300275 Novel Benzothiazolone Derivatives
12/04/2008US20080300269 Glaucoma; prostaglandin receptor modulators; cyclopentyl compounds such as 5-{3-[(1S,5S)-5-(3-Chloro-5-hydroxymethyl-phenoxymethyl)-4-oxo-cyclopent-2-enyl]-propyl}-thiophene-2-carboxylic acid
12/04/2008US20080300259 Multimediator 5-Ht6 Receptor Antagonists, and Uses Related Thereto
12/04/2008US20080300243 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/04/2008US20080300136 2-(3-Chlorobenzoyl)amino-N-(2,6-dimethyl-4-heptafluoro- isopropylphenyl)-1,3-thiazole-4-carboxamide; treating transgenic seeds and plants; sanitation; preservatives; alkali resistance; residue in wood
12/04/2008US20080299041 Heterocyclic indene derivatives and their radioisotope labeled compounds for imaging beta-amyloid deposition
12/04/2008CA2686651A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/03/2008EP1997800A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
12/03/2008EP1997489A1 Adamantylglycine derivatives as inhibitors of dipeptidyl peptidase IV for the treatment of diabetes
12/03/2008EP1996567A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
12/03/2008EP1996566A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists
12/03/2008EP1996565A2 Substituted aminothiazole derivatives with anti-hcv activity
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 337